Literature DB >> 1424041

Abolishment of chronic volume overload. Implications for diastolic function of the systemic ventricle immediately after Fontan repair.

M Gewillig1, W Daenen, A Aubert, L Van der Hauwaert.   

Abstract

BACKGROUND: In patients with a univentricular heart, the chronic ventricular volume overload is acutely abolished by the creation of a Fontan circuit. This results in an immediate reduction of the ventricular cavity size but also in an inappropriate degree of ventricular wall thickness, at least in the early postoperative period. The implications for the diastolic properties of the ventricle are poorly understood. METHODS AND
RESULTS: A chronic volume overload through a modified Blalock-Taussig shunt was created in 10 mongrel dogs. Six weeks later, the shunt was occluded percutaneously with a detachable balloon. The left ventricular end-diastolic dimension and posterior wall thickness were measured with transcutaneous echocardiography. Digitized high-fidelity pressure tracings were used to determine the time constant of isovolumic pressure decay, tau. The isovolumic relaxation time (A2-MVO) and time to minimal left ventricular pressure (A2-LVPmin) were recorded. All variables were followed up to 1 month after occlusion of the shunt. One hour after occlusion, there was an incomplete return to baseline values of the echocardiographic left ventricular dimension (+12 +/- 8% of baseline value, p < 0.01). Despite a 31 +/- 14% (p < 0.001) increase of the posterior wall thickness after removal of the volume overload, tau or ventricular relaxation showed no change from control values. In contrast, the early filling wave was blunted, suggesting diminished ventricular suction. A2-MVO (p < 0.01) and A2-LVPmin (p < 0.05) lengthened well above baseline values for up to 1 week after occlusion of the shunt. Over the following month, the volume-induced hypertrophy regressed, and indexes of early ventricular filling resumed control values.
CONCLUSIONS: We conclude that early after removal of a chronic volume overload, the resultant increase of wall thickness is not associated with impaired relaxation but that viscosity and inertia caused by the increased mass-to-volume ratio will impair early ventricular filling.

Entities:  

Mesh:

Year:  1992        PMID: 1424041

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Effects of arteriovenous shunt on ventricular function in dog.

Authors:  T Omoto; R Aeba; T Katogi; T Ito; S Kawada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-03

Review 2.  The Lymphatic Circulation in Adaptations to the Fontan Circulation.

Authors:  Sabarinath Menon; Murthy Chennapragada; Shinya Ugaki; Gary F Sholler; Julian Ayer; David S Winlaw
Journal:  Pediatr Cardiol       Date:  2017-02-16       Impact factor: 1.655

3.  The total artificial heart in patients with congenital heart disease.

Authors:  Karthik Thangappan; Awais Ashfaq; Chet Villa; David L S Morales
Journal:  Ann Cardiothorac Surg       Date:  2020-03

4.  Quantification of ventricular unloading by 3D echocardiography in single ventricle of left ventricular morphology following superior cavo-pulmonary anastomosis and Fontan completion - a feasibility study.

Authors:  Deepa Sasikumar; Bijulal Sasidharan; Baiju S Dharan; Arun Gopalakrishnan; Kavasseri M Krishnamoorthy; Sivasubramanian Sivasankaran
Journal:  Ann Pediatr Cardiol       Date:  2017 Sep-Dec

Review 5.  The Total Artificial Heart in End-Stage Congenital Heart Disease.

Authors:  Chet R Villa; David L S Morales
Journal:  Front Physiol       Date:  2017-05-09       Impact factor: 4.566

Review 6.  Late Fontan Circulatory Failure. What Drives Systemic Venous Congestion and Low Cardiac Output in Adult Fontan Patients?

Authors:  Alexander Van De Bruaene; Guido Claessen; Thomas Salaets; Marc Gewillig
Journal:  Front Cardiovasc Med       Date:  2022-03-14

Review 7.  The Fontan circulation after 45 years: update in physiology.

Authors:  Marc Gewillig; Stephen C Brown
Journal:  Heart       Date:  2016-05-24       Impact factor: 5.994

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.